UK investor profile and portfolio
Oxford Science Enterprises
12 UK company relationship(s) retained from funding evidence.
2 as lead
UK portfolio companies
- Beacon TherapeuticsLondon
- First Light FusionSouth East
- Genomics plcSouth East
- Grey Wolf TherapeuticsSouth East
- MiroBioSouth East
- OMass TherapeuticsSouth East
- ORCA ComputingLondon
- Oxford Quantum CircuitsSouth East
- PQShieldSouth East
- Quantum MotionLondon
- Sitryx TherapeuticsSouth East
- UltromicsSouth East
Sources
- https://www.prnewswire.com/news-releases/beacon-therapeutics-raises-170-million-in-series-b-funding-to-advance-development-of-ophthalmic-gene-therapies-302188599.html
- https://www.massbio.org/members/beacon-therapeutics/
- https://www.oxfordscienceenterprises.com/portfolio
- https://firstlightfusion.com/media/first-light-fusion-announces-close-of-series-c-fund-raise/
- https://news.crunchbase.com/startups/investors-fired-up-about-fusion-as-first-light-fusion-sparks-series-c/
- https://firstlightfusion.com/media/first-light-fusion-announces-close-of-series-c-fund-raises/
- https://www.finsmes.com/2022/02/first-light-fusion-closes-45m-in-series-c-funding.html
- https://www.biopharmadive.com/news/gilead-mirobio-deal-autoimmune/628941/
- https://www.ox.ac.uk/news/2022-08-04-oxford-spinout-mirobio-acquired-gilead-sciences-405m
- https://www.uktech.news/medtech/omass-therapeutics-10m-20230515
- https://thebusinessmagazine.co.uk/companies/oxford-spin-out-omass-raises-75million-in-financing-round/
- https://pqshield.com/pqshield-raises-37m-in-series-b-funding/
- https://sifted.eu/articles/quantum-pqshield-seriesb-raise-news
- https://www.uktech.news/cybersecurity/pqshield-post-quantum-funding-20240620
- https://svhealthinvestors.com/news/sitryx-raises-additional-39-million-to-progress-development-of-disease-modifying-therapeutics-for-chronic-autoimmune-and-inflammatory-diseases
- https://www.globenewswire.com/news-release/2023/09/27/2750055/0/en/Sitryx-raises-additional-39-million-to-progress-development-of-disease-modifying-therapeutics-for-chronic-autoimmune-and-inflammatory-disease.html